Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 102

Results For "sales"

1324 News Found

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


Lupin engages Flutura to accelerate digitial drive using AI
News | April 21, 2022

Lupin engages Flutura to accelerate digitial drive using AI

Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact on Pharmaceutical outcomes


Dr. Reddy's launch Posaconazole delayed-release tablets in the US
Drug Approval | April 21, 2022

Dr. Reddy's launch Posaconazole delayed-release tablets in the US

The tablets are available in 100 mg strength in bottle count sizes of 60


Purigen launches ionic cells to pure DNA kit
Biotech | April 21, 2022

Purigen launches ionic cells to pure DNA kit

New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques


SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system
Drug Approval | April 18, 2022

SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system

The HD-550 endoscopy system has been available outside of the USA since 2019


Amneal achieves second U.S. biosimilars approval with Alymsys
Drug Approval | April 18, 2022

Amneal achieves second U.S. biosimilars approval with Alymsys

Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022


GSK to acquire Sierra Oncology for US $1.9bn
Biotech | April 18, 2022

GSK to acquire Sierra Oncology for US $1.9bn

Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022


Geocann and Averix Bio to partner on API phytocannabinoid ingredients
News | April 18, 2022

Geocann and Averix Bio to partner on API phytocannabinoid ingredients

This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors


Fujifilm India completes installation of 50,000 medical devices in India
Medical Device | April 18, 2022

Fujifilm India completes installation of 50,000 medical devices in India

Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians


Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
Drug Approval | April 18, 2022

Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets

This product will be manufactured at Lupin’s Nagpur facility in India